placebo-controlled study enrolling 263 adults aged 18 to 75 years with obesity or overweight plus at least one obesity-related comorbidity excluding those with type 2 diabetes
have been diagnosed with gastroparesis, stomach paralysis or another potentially related gastric injury or disorder, or have undergone gastric bypass surgery, while either still taking the medication or within 6 months of stopping What to do
Ready to start your transformation
Employer exclusions, diagnosis criteria, prior authorization, and step therapy can differ even within one insurer
Therapy can be paused, adjusted, or combined with other peptides such as Tesamorelin, BPC-157, or Sermorelin depending on your goals and progress
The Florida Department of Children and Families oversees providers to ensure they meet standards set by the Substance Abuse and Mental Health Services Administration (SAMHSA)